News

Company News & Events

EpigenomicsNet features Oryzon CSO Tamara Maes on Epigenetic drug development

2 June 2016

CSO Tamara Maes is interviewed on the development of the epigenetic drug ORY-2001 for treatment of neurodegenerative diseases.

Please sign up at https://www.epigenomicsnet.com/ to view the interview.

Posted In: 
Noticias

Share this story